If you have patients who take medication(s) for fertility treatment, we want to make you aware that on Feb. 19, 2026, Optum Specialty Pharmacy exited the fertility pharmacy business and is no longer filling fertility prescriptions. Fuze Health is now the dispensing pharmacy for the medications listed below, as well as any adjacent medications taken by your patients. 

  • Cetrorelix
  • Cetrotide
  • Follistim
  • Ganirelix 
  • Gonal-F 
  • Human chorionic gonadotropin (hCG)
  • Menopur
  • Novarel
  • Ovidrel
  • Pregnyl

To ensure a seamless transition for patients on these fertility medications, in early February Optum Specialty Pharmacy notified impacted members by mail of the pharmacy change. Members currently in an active treatment cycle with an open prescription will be allowed to remain with Optum Specialty Pharmacy until the completion of the cycle with no action required on their part; they will not need to transition to Fuze Health. 

Any members with a new prescription for an impacted fertility medication not yet filled through Optum Specialty Pharmacy will transition to Fuze Health. If the prescription is received by Optum Specialty Pharmacy on or after Feb. 19, they will facilitate the transition of the prescription to Fuze Health.

We anticipate this transition to be seamless for both you and your patients. To initiate a new fertility medication prescription, you may call Fuze Health at 800-305-0542.

Optum Specialty Pharmacy will continue to be the designated specialty pharmacy for certain other medications including those used to treat hepatitis C, growth hormone deficiency, multiple sclerosis, rheumatoid arthritis, cancers, and other conditions and diseases. To learn more, refer to the specialty pharmacy sections of the Harvard Pilgrim Health Care and Tufts Health Public Plans Provider Manuals.